LMNL Annual EBITDA
-$20.94 M
+$6.40 M+23.40%
31 December 2022
Summary:
As of February 1, 2025, LMNL annual earnings before interest, taxes, depreciation & amortization is -$20.94 million, with the most recent change of +$6.40 million (+23.40%) on December 31, 2022. During the last 3 years, it has risen by +$80.12 million (+79.28%).LMNL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Quarterly EBITDA
-$6.69 M
-$1.27 M-23.34%
30 June 2023
Summary:
As of February 1, 2025, LMNL quarterly earnings before interest, taxes, depreciation & amortization is -$6.69 million, with the most recent change of -$1.27 million (-23.34%) on June 30, 2023. Over the past year, it has dropped by -$2.51 million (-59.95%).LMNL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL TTM EBITDA
-$23.10 M
-$2.51 M-12.18%
30 June 2023
Summary:
As of February 1, 2025, LMNL TTM earnings before interest, taxes, depreciation & amortization is -$23.10 million, with the most recent change of -$2.51 million (-12.18%) on June 30, 2023. Over the past year, it has dropped by -$843.70 thousand (-3.79%).LMNL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.4% | -60.0% | -3.8% |
| 3 y3 years | +79.3% | +12.2% | -56.4% |
| 5 y5 years | +78.1% | +67.7% | +76.9% |
LMNL EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -639.6% | -122.3% | -547.9% |
Liminal BioSciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$6.69 M(+23.3%) | -$23.10 M(+12.2%) |
| Mar 2023 | - | -$5.43 M(+5.6%) | -$20.59 M(-9.3%) |
| Dec 2022 | -$20.94 M(-23.4%) | -$5.14 M(-12.0%) | -$22.70 M(+0.8%) |
| Sept 2022 | - | -$5.84 M(+39.6%) | -$22.51 M(+1.1%) |
| June 2022 | - | -$4.18 M(-44.4%) | -$22.26 M(-13.6%) |
| Mar 2022 | - | -$7.53 M(+51.9%) | -$25.77 M(-5.7%) |
| Dec 2021 | -$27.34 M(-3.3%) | -$4.96 M(-11.3%) | -$27.34 M(-6.3%) |
| Sept 2021 | - | -$5.59 M(-27.4%) | -$29.17 M(-2.3%) |
| June 2021 | - | -$7.70 M(-15.5%) | -$29.86 M(+0.2%) |
| Mar 2021 | - | -$9.10 M(+34.2%) | -$29.79 M(-22.9%) |
| Dec 2020 | -$28.27 M(-72.0%) | -$6.78 M(+8.0%) | -$38.64 M(+2008.0%) |
| Sept 2020 | - | -$6.28 M(-17.6%) | -$1.83 M(-87.6%) |
| June 2020 | - | -$7.63 M(-57.5%) | -$14.77 M(-85.7%) |
| Mar 2020 | - | -$17.96 M(-159.8%) | -$103.42 M(+3.3%) |
| Dec 2019 | -$101.06 M(-44.1%) | $30.03 M(-256.2%) | -$100.15 M(-59.0%) |
| Sept 2019 | - | -$19.22 M(-80.0%) | -$244.54 M(-0.2%) |
| June 2019 | - | -$96.28 M(+555.7%) | -$245.13 M(+44.6%) |
| Mar 2019 | - | -$14.68 M(-87.2%) | -$169.56 M(-5.3%) |
| Dec 2018 | -$180.77 M(+89.3%) | -$114.35 M(+477.2%) | -$178.96 M(+69.5%) |
| Sept 2018 | - | -$19.81 M(-4.4%) | -$105.58 M(+9.0%) |
| June 2018 | - | -$20.71 M(-14.0%) | -$96.83 M(-1.4%) |
| Mar 2018 | - | -$24.09 M(-41.2%) | -$98.23 M(+3.0%) |
| Dec 2017 | -$95.51 M(+15.9%) | -$40.97 M(+270.5%) | -$95.34 M(+13.6%) |
| Sept 2017 | - | -$11.06 M(-50.0%) | -$83.92 M(-10.6%) |
| June 2017 | - | -$22.11 M(+4.3%) | -$93.82 M(+3.4%) |
| Mar 2017 | - | -$21.19 M(-28.3%) | -$90.72 M(+9.9%) |
| Dec 2016 | -$82.43 M(+87.0%) | -$29.56 M(+41.0%) | -$82.56 M(+32.9%) |
| Sept 2016 | - | -$20.96 M(+10.3%) | -$62.14 M(+26.6%) |
| June 2016 | - | -$19.01 M(+45.8%) | -$49.10 M(+19.0%) |
| Mar 2016 | - | -$13.04 M(+42.6%) | -$41.26 M(-7.0%) |
| Dec 2015 | -$44.08 M(-1235.9%) | -$9.14 M(+15.4%) | -$44.35 M(+51.2%) |
| Sept 2015 | - | -$7.92 M(-29.1%) | -$29.32 M(-25.4%) |
| June 2015 | - | -$11.16 M(-30.8%) | -$39.30 M(+593.6%) |
| Mar 2015 | - | -$16.12 M(-374.0%) | -$5.67 M(-252.5%) |
| Dec 2014 | $3.88 M(-127.5%) | $5.88 M(-132.9%) | $3.71 M(-145.0%) |
| Sept 2014 | - | -$17.89 M(-179.6%) | -$8.26 M(-260.1%) |
| June 2014 | - | $22.47 M(-433.1%) | $5.16 M(-126.8%) |
| Mar 2014 | - | -$6.74 M(+10.8%) | -$19.23 M(+37.2%) |
| Dec 2013 | -$14.13 M(-868.6%) | -$6.09 M(+36.0%) | -$14.02 M(+121.5%) |
| Sept 2013 | - | -$4.48 M(+132.8%) | -$6.33 M(-638.5%) |
| June 2013 | - | -$1.92 M(+25.7%) | $1.17 M(-73.5%) |
| Mar 2013 | - | -$1.53 M(-195.5%) | $4.43 M(+138.5%) |
| Dec 2012 | $1.84 M(-258.6%) | $1.60 M(-47.1%) | $1.86 M(-54.0%) |
| Sept 2012 | - | $3.03 M(+126.5%) | $4.04 M(-806.6%) |
| June 2012 | - | $1.34 M(-132.5%) | -$572.20 K(-82.7%) |
| Mar 2012 | - | -$4.10 M(-208.4%) | -$3.30 M(+172.5%) |
| Dec 2011 | -$1.16 M(-85.9%) | $3.79 M(-338.1%) | -$1.21 M(-85.6%) |
| Sept 2011 | - | -$1.59 M(+14.1%) | -$8.41 M(-10.0%) |
| June 2011 | - | -$1.39 M(-30.8%) | -$9.34 M(+12.8%) |
| Mar 2011 | - | -$2.01 M(-41.0%) | -$8.29 M(-5.1%) |
| Dec 2010 | -$8.22 M | -$3.41 M(+35.1%) | -$8.73 M(+36.3%) |
| Sept 2010 | - | -$2.53 M(+653.3%) | -$6.41 M(+72.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | -$335.30 K(-86.4%) | -$3.70 M(-46.0%) |
| Mar 2010 | - | -$2.46 M(+126.9%) | -$6.86 M(+26.0%) |
| Dec 2009 | -$5.56 M(-60.6%) | -$1.08 M(-716.5%) | -$5.44 M(-26.1%) |
| Sept 2009 | - | $175.90 K(-105.0%) | -$7.37 M(-26.8%) |
| June 2009 | - | -$3.49 M(+232.8%) | -$10.06 M(-8.4%) |
| Mar 2009 | - | -$1.05 M(-65.2%) | -$10.98 M(-23.6%) |
| Dec 2008 | -$14.11 M(-12.6%) | -$3.01 M(+19.7%) | -$14.37 M(-11.0%) |
| Sept 2008 | - | -$2.52 M(-42.9%) | -$16.14 M(-15.0%) |
| June 2008 | - | -$4.41 M(-0.6%) | -$18.99 M(+6.7%) |
| Mar 2008 | - | -$4.43 M(-7.3%) | -$17.80 M(+9.2%) |
| Dec 2007 | -$16.15 M(-8.0%) | -$4.78 M(-10.9%) | -$16.30 M(+0.3%) |
| Sept 2007 | - | -$5.37 M(+67.1%) | -$16.25 M(-2.2%) |
| June 2007 | - | -$3.21 M(+9.5%) | -$16.62 M(+0.3%) |
| Mar 2007 | - | -$2.93 M(-38.0%) | -$16.58 M(-6.9%) |
| Dec 2006 | -$17.55 M(+76.7%) | -$4.73 M(-17.6%) | -$17.80 M(+13.6%) |
| Sept 2006 | - | -$5.74 M(+81.0%) | -$15.67 M(+17.2%) |
| June 2006 | - | -$3.17 M(-23.6%) | -$13.37 M(-3.2%) |
| Mar 2006 | - | -$4.15 M(+59.5%) | -$13.82 M(+39.1%) |
| Dec 2005 | -$9.93 M(+13.5%) | -$2.60 M(-24.3%) | -$9.93 M(+4.4%) |
| Sept 2005 | - | -$3.44 M(-4.9%) | -$9.51 M(+9.0%) |
| June 2005 | - | -$3.62 M(+1240.1%) | -$8.73 M(+54.2%) |
| Mar 2005 | - | -$270.00 K(-87.6%) | -$5.66 M(-36.1%) |
| Dec 2004 | -$8.75 M(-31.4%) | -$2.18 M(-17.9%) | -$8.86 M(-14.9%) |
| Sept 2004 | - | -$2.66 M(+381.0%) | -$10.40 M(-4.1%) |
| June 2004 | - | -$552.20 K(-84.1%) | -$10.84 M(-21.4%) |
| Mar 2004 | - | -$3.47 M(-6.9%) | -$13.79 M(+7.6%) |
| Dec 2003 | -$12.76 M(+52.2%) | -$3.73 M(+20.4%) | -$12.81 M(+10.2%) |
| Sept 2003 | - | -$3.10 M(-11.5%) | -$11.63 M(+11.7%) |
| June 2003 | - | -$3.50 M(+40.2%) | -$10.41 M(+14.2%) |
| Mar 2003 | - | -$2.49 M(-1.9%) | -$9.11 M(+8.6%) |
| Dec 2002 | -$8.39 M(+72.8%) | -$2.54 M(+35.8%) | -$8.39 M(+15.3%) |
| Sept 2002 | - | -$1.87 M(-15.0%) | -$7.27 M(+12.1%) |
| June 2002 | - | -$2.20 M(+24.3%) | -$6.49 M(+16.3%) |
| Mar 2002 | - | -$1.77 M(+24.2%) | -$5.58 M(+15.2%) |
| Dec 2001 | -$4.85 M(+60.7%) | -$1.43 M(+30.9%) | -$4.84 M(+18.2%) |
| Sept 2001 | - | -$1.09 M(-15.8%) | -$4.10 M(+4.9%) |
| June 2001 | - | -$1.29 M(+25.2%) | -$3.91 M(+18.8%) |
| Mar 2001 | - | -$1.03 M(+52.0%) | -$3.29 M(+14.4%) |
| Dec 2000 | -$3.02 M(+35.9%) | -$680.20 K(-24.4%) | -$2.88 M(+218.0%) |
| Sept 2000 | - | -$900.20 K(+33.3%) | -$904.00 K(-29.5%) |
| June 2000 | - | -$675.50 K(+9.1%) | -$1.28 M(-27.2%) |
| Mar 2000 | - | -$619.20 K(-148.0%) | -$1.76 M(-19.9%) |
| Dec 1999 | -$2.22 M(+26.6%) | $1.29 M(-201.0%) | -$2.20 M(-44.2%) |
| Sept 1999 | - | -$1.28 M(+10.7%) | -$3.94 M(+23.5%) |
| June 1999 | - | -$1.15 M(+9.1%) | -$3.19 M(-0.7%) |
| Mar 1999 | - | -$1.06 M(+133.0%) | -$3.22 M(+0.3%) |
| Dec 1998 | -$1.76 M(-41.4%) | -$454.00 K(-14.1%) | -$3.21 M(-17.5%) |
| Sept 1998 | - | -$528.60 K(-55.0%) | -$3.89 M(+15.7%) |
| June 1998 | - | -$1.18 M(+12.0%) | -$3.36 M(+53.8%) |
| Mar 1998 | - | -$1.05 M(-7.6%) | -$2.19 M(+92.4%) |
| Dec 1997 | - | -$1.14 M | -$1.14 M |
| Sept 1997 | -$2.99 M | - | - |
FAQ
- What is Liminal BioSciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Liminal BioSciences?
- What is Liminal BioSciences annual EBITDA year-on-year change?
- What is Liminal BioSciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Liminal BioSciences?
- What is Liminal BioSciences quarterly EBITDA year-on-year change?
- What is Liminal BioSciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Liminal BioSciences?
- What is Liminal BioSciences TTM EBITDA year-on-year change?
What is Liminal BioSciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of LMNL is -$20.94 M
What is the all time high annual EBITDA for Liminal BioSciences?
Liminal BioSciences all-time high annual earnings before interest, taxes, depreciation & amortization is $3.88 M
What is Liminal BioSciences annual EBITDA year-on-year change?
Over the past year, LMNL annual earnings before interest, taxes, depreciation & amortization has changed by +$6.40 M (+23.40%)
What is Liminal BioSciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of LMNL is -$6.69 M
What is the all time high quarterly EBITDA for Liminal BioSciences?
Liminal BioSciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $30.03 M
What is Liminal BioSciences quarterly EBITDA year-on-year change?
Over the past year, LMNL quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.51 M (-59.95%)
What is Liminal BioSciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of LMNL is -$23.10 M
What is the all time high TTM EBITDA for Liminal BioSciences?
Liminal BioSciences all-time high TTM earnings before interest, taxes, depreciation & amortization is $5.16 M
What is Liminal BioSciences TTM EBITDA year-on-year change?
Over the past year, LMNL TTM earnings before interest, taxes, depreciation & amortization has changed by -$843.70 K (-3.79%)